Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
---|---|---|---|---|---|---|---|---|
VRDN | VIRIDIAN THERAPEUTICS INC | United States | $1.10B | 62,767,570 | 67.46% | 32.54% | Net Buying | Net Buying |
OCS | OCULIS HOLDING AG | Switzerland | $441.63M | 36,649,705 | 10.87% | 0.00% | ||
CRNX | CRINETICS PHARMACEUTICALS INC | United States | $3.26B | 69,596,202 | 85.02% | 14.98% | Net Selling | Net Selling |
PRTC | PURETECH HEALTH PLC | United States | $793.91M | 278,566,306 | 0.00% | 0.00% | ||
ZVRA | ZEVRA THERAPEUTICS INC | United States | $210.07M | 36,218,164 | 35.01% | 33.38% | Net Buying | |
STTK | SHATTUCK LABS INC | United States | $424.42M | 47,474,783 | 56.96% | 26.50% | Net Selling | Net Selling |
IFRX | INFLARX NV | Germany | $90.68M | 58,883,272 | 29.00% | 0.00% | ||
VCYT | VERACYTE INC | United States | $1.66B | 75,067,823 | 64.44% | 35.56% | Net Selling | Net Selling |
MGNX | MACROGENICS INC | United States | $919.00M | 62,432,013 | 72.53% | 27.47% | Net Buying | Net Selling |
CMRX | CHIMERIX INC | United States | $94.56M | 89,210,356 | 45.42% | 31.91% | Net Buying | Net Selling |
DTIL | PRECISION BIOSCIENCES INC | United States | $93.78M | 6,916,239 | 53.55% | 46.45% | Net Selling | Net Selling |
BLUE | BLUEBIRD BIO INC | United States | $139.95M | 109,336,211 | 91.17% | 8.83% | Net Selling | Net Selling |
DNTH | DIANTHUS THERAPEUTICS INC | United States | $880.40M | 29,346,760 | 26.69% | 73.31% | Net Buying | Net Buying |
CASI | CASI PHARMACEUTICALS INC | China | $48.30M | 13,378,175 | 0.35% | 99.65% | ||
BOLT | BOLT BIOTHERAPEUTICS INC | United States | $53.38M | 38,127,740 | 54.74% | 45.26% | Net Selling | |
NTBL | NOTABLE LABS LTD | Israel | $15.93M | 9,001,320 | 2.63% | 97.37% | Net Selling | Net Selling |
ATAI | ATAI LIFE SCIENCES NV | United States | $327.07M | 166,026,396 | 7.99% | 37.99% | Net Buying | |
LQDA | LIQUIDIA CORP | United States | $1.12B | 76,027,776 | 37.69% | 62.31% | Net Buying | Net Selling |
AUPH | AURINIA PHARMACEUTICALS INC | Canada | $724.53M | 144,617,762 | 36.80% | 3.18% | Net Selling | Net Selling |
CRBU | CARIBOU BIOSCIENCES INC | United States | $464.22M | 90,314,501 | 76.47% | 8.74% | Net Buying | Net Buying |
YMAB | Y-MABS THERAPEUTICS INC | United States | $711.82M | 43,777,105 | 46.22% | 39.32% | Net Buying | Net Selling |
BEAM | BEAM THERAPEUTICS INC | United States | $2.70B | 81,657,714 | 78.64% | 21.36% | Net Selling | Net Selling |
QNCX | QUINCE THERAPEUTICS INC | United States | $45.44M | 42,868,947 | 15.43% | 84.57% | Net Buying | Net Buying |
CYCN | CYCLERION THERAPEUTICS INC | United States | $8.67M | 2,710,096 | 9.83% | 90.17% | Net Buying | |
ARVN | ARVINAS INC | United States | $2.81B | 68,083,928 | 74.74% | 25.26% | Net Selling | Net Selling |
KROS | KEROS THERAPEUTICS INC | United States | $2.38B | 35,982,628 | 70.92% | 29.08% | Net Buying | |
CCCC | C4 THERAPEUTICS INC | United States | $560.47M | 68,600,669 | 68.39% | 25.29% | Net Buying | Net Selling |
CELZ | CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC | United States | $7.07M | 1,356,626 | 1.45% | 3.94% | Net Buying | |
CALT | CALLIDITAS THERAPEUTICS AB | Sweden | $625.89M | 59,580,087 | 1.42% | 0.00% | ||
INO | INOVIO PHARMACEUTICALS INC | United States | $324.38M | 23,370,365 | 61.56% | 38.44% | Net Selling | Net Selling |
LYEL | LYELL IMMUNOPHARMA INC | United States | $566.63M | 254,096,311 | 51.66% | 46.21% | Net Selling | |
XOMA | XOMA CORP | United States | $279.60M | 11,625,826 | 17.69% | 82.31% | Net Buying | |
CUE | CUE BIOPHARMA INC | United States | $91.94M | 48,643,316 | 30.59% | 9.31% | Net Buying | |
GLYC | GLYCOMIMETICS INC | United States | $193.35M | 64,450,385 | 35.53% | 64.47% | Net Buying | |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | United States | $959.42M | 96,813,363 | 73.21% | 26.79% | Net Buying | Net Selling |
IKNA | IKENA ONCOLOGY INC | United States | $68.53M | 48,258,111 | 66.60% | 18.22% | ||
ALLO | ALLOGENE THERAPEUTICS INC | United States | $755.84M | 169,091,992 | 60.41% | 39.59% | Net Selling | Net Selling |
GTHX | G1 THERAPEUTICS INC | United States | $225.50M | 52,199,394 | 24.18% | 47.08% | Net Selling | Net Selling |
NTLA | INTELLIA THERAPEUTICS INC | United States | $2.64B | 96,106,405 | 68.94% | 31.06% | Net Selling | Net Selling |
OCUL | OCULAR THERAPEUTIX INC | United States | $1.35B | 148,627,439 | 49.43% | 21.84% | Net Buying | Net Buying |
PGEN | PRECIGEN INC | United States | $360.93M | 248,919,096 | 25.15% | 72.66% | Net Buying | Net Buying |
DNLI | DENALI THERAPEUTICS INC | United States | $2.86B | 139,160,239 | 56.48% | 43.52% | Net Selling | Net Selling |
SWTX | SPRINGWORKS THERAPEUTICS INC | United States | $3.63B | 73,786,845 | 64.08% | 35.92% | Net Selling | Net Selling |
TFFP | TFF PHARMACEUTICALS INC | United States | $14.29M | 2,365,343 | 3.16% | 96.84% | Net Buying | |
QTTB | Q32 BIO INC | United States | $55.03M | 3,229,641 | 47.07% | 52.93% | Net Selling | Net Selling |
MRNA | MODERNA INC | United States | $40.71B | 382,073,208 | 67.29% | 21.68% | Net Selling | Net Selling |
MIST | MILESTONE PHARMACEUTICALS INC | Canada | $95.14M | 53,149,778 | 33.44% | 24.16% | ||
TCRT | ALAUNOS THERAPEUTICS INC | United States | $29.04M | 16,041,804 | 53.35% | 46.65% | Net Selling | |
ABCL | ABCELLERA BIOLOGICS INC | Canada | $1.33B | 292,782,152 | 40.68% | 47.55% | Net Buying | Net Buying |
PLUR | PLURI INC | Israel | $33.43M | 41,480,172 | 0.58% | 99.42% | ||
ELDN | ELEDON PHARMACEUTICALS INC | United States | $51.12M | 24,813,130 | 23.14% | 76.86% | ||
LYRA | LYRA THERAPEUTICS INC | United States | $371.60M | 59,743,123 | 70.88% | 14.48% | Net Buying | |
INVA | INNOVIVA INC | United States | $963.58M | 63,227,333 | 58.68% | 41.32% | Net Buying | Net Buying |
NGNE | NEUROGENE INC | United States | $654.22M | 12,852,985 | 36.48% | 63.52% | Net Buying | |
SLRN | ACELYRIN INC | United States | $663.96M | 98,365,050 | 73.06% | 26.94% | Net Buying | Net Selling |
LUMO | LUMOS PHARMA INC | United States | $22.86M | 8,107,121 | 17.72% | 82.28% | Net Selling | Net Selling |
VIR | VIR BIOTECHNOLOGY INC | United States | $1.37B | 135,032,268 | 62.23% | 37.77% | Net Selling | Net Selling |
LPTX | LEAP THERAPEUTICS INC | United States | $68.10M | 25,600,137 | 13.55% | 86.45% | ||
ALPN | ALPINE IMMUNE SCIENCES INC | United States | $2.60B | 65,546,136 | 59.44% | 40.56% | Net Buying | Net Buying |
COCP | COCRYSTAL PHARMA INC | United States | $14.24M | 10,173,790 | 0.69% | 99.31% | Net Buying | |
KTTA | PASITHEA THERAPEUTICS CORP | United States | $7.55M | 1,041,831 | 2.22% | 97.78% | Net Buying | |
ABSI | ABSCI CORP | United States | $640.62M | 112,784,576 | 29.91% | 39.04% | Net Buying | Net Buying |
IOBT | IO BIOTECH INC | Denmark | $113.97M | 65,880,914 | 36.62% | 63.38% | Net Buying | Net Selling |
CLDX | CELLDEX THERAPEUTICS INC | United States | $2.35B | 55,900,679 | 82.75% | 17.25% | Net Buying | Net Buying |
PMCB | PHARMACYTE BIOTECH INC | United States | $20.06M | 8,464,824 | 12.86% | 13.29% | ||
LRMR | LARIMAR THERAPEUTICS INC | United States | $484.24M | 63,800,017 | 42.05% | 57.95% | Net Buying | Net Buying |
TVTX | TRAVERE THERAPEUTICS INC | United States | $586.72M | 76,098,485 | 59.75% | 40.25% | Net Selling | Net Selling |
AVXL | ANAVEX LIFE SCIENCES CORP | United States | $417.95M | 82,112,511 | 31.49% | 5.04% | Net Buying | |
TBPH | THERAVANCE BIOPHARMA INC | Cayman Islands | $432.04M | 48,164,708 | 60.71% | 39.29% | Net Selling | Net Selling |
CABA | CABALETTA BIO INC | United States | $823.00M | 48,241,615 | 92.00% | 8.00% | Net Buying | Net Buying |
MOLN | MOLECULAR PARTNERS AG | Switzerland | $137.99M | 32,854,297 | 2.91% | 0.00% | ||
TCRX | TSCAN THERAPEUTICS INC | United States | $380.18M | 47,882,196 | 66.65% | 29.73% | Net Buying | |
ENTX | ENTERA BIO LTD | Israel | $59.25M | 35,481,341 | 11.45% | 3.46% | Net Buying | Net Buying |
VRNA | VERONA PHARMA PLC | United Kingdom | $1.30B | 646,524,958 | 10.44% | 55.94% | Net Selling | Net Selling |
CRDF | CARDIFF ONCOLOGY INC | United States | $238.58M | 44,677,169 | 11.85% | 34.59% | Net Buying | |
ATXS | ASTRIA THERAPEUTICS INC | United States | $772.76M | 54,903,061 | 67.13% | 25.09% | Net Buying | Net Buying |
DNA | GINKGO BIOWORKS HOLDINGS INC | United States | $2.50B | 2,152,395,786 | 58.22% | 13.97% | Net Selling | Net Selling |
TRVI | TREVI THERAPEUTICS INC | United States | $237.91M | 68,960,167 | 22.22% | 77.78% | Net Buying | |
RIGL | RIGEL PHARMACEUTICALS INC | United States | $259.56M | 175,377,812 | 60.76% | 15.75% | Net Selling | Net Selling |
LABP | LANDOS BIOPHARMA INC | United States | $66.95M | 3,116,729 | 4.53% | 95.47% | ||
ATOS | ATOSSA THERAPEUTICS INC | United States | $225.55M | 125,304,064 | 12.74% | 15.20% | Net Buying | |
APRE | APREA THERAPEUTICS INC | United States | $36.33M | 5,430,215 | 1.54% | 98.46% | Net Buying | Net Buying |
VCEL | VERICEL CORP | United States | $2.51B | 48,290,164 | 91.23% | 8.77% | Net Selling | Net Selling |
RLAY | RELAY THERAPEUTICS INC | United States | $1.09B | 131,179,034 | 72.36% | 27.64% | Net Selling | Net Selling |
ETNB | 89BIO INC | United States | $1.09B | 93,501,210 | 85.94% | 14.06% | Net Buying | Net Buying |
BPMC | BLUEPRINT MEDICINES CORP | United States | $5.81B | 61,232,297 | 81.64% | 18.36% | Net Selling | Net Selling |
SVRA | SAVARA INC | United States | $687.98M | 138,148,141 | 32.29% | 67.71% | Net Buying | |
AKRO | AKERO THERAPEUTICS INC | United States | $1.42B | 56,297,528 | 66.82% | 33.18% | Net Buying | Net Buying |
EVGN | EVOGENE LTD | Israel | $37.94M | 50,584,588 | 8.48% | 0.00% | ||
HOWL | WEREWOLF THERAPEUTICS INC | United States | $276.94M | 42,737,191 | 48.08% | 51.92% | ||
TERN | TERNS PHARMACEUTICALS INC | United States | $424.12M | 64,651,693 | 72.17% | 27.83% | Net Buying | |
ELVN | ENLIVEN THERAPEUTICS INC | United States | $727.30M | 41,347,632 | 46.24% | 53.76% | Net Selling | Net Selling |
LSTA | LISATA THERAPEUTICS INC | United States | $25.92M | 8,307,433 | 0.84% | 99.16% | Net Selling | Net Selling |
ACAD | ACADIA PHARMACEUTICALS INC | United States | $3.05B | 164,771,521 | 71.23% | 28.77% | Net Buying | Net Selling |
TTNP | TITAN PHARMACEUTICALS INC | United States | $5.38M | 750,815 | 2.50% | 97.50% | Net Selling | |
ANAB | ANAPTYSBIO INC | United States | $602.70M | 26,763,081 | 41.94% | 58.06% | Net Selling | Net Selling |
DMAC | DIAMEDICA THERAPEUTICS INC | United States | $105.14M | 37,958,000 | 10.12% | 55.46% | Net Buying | Net Buying |
FDMT | 4D MOLECULAR THERAPEUTICS INC | United States | $1.59B | 49,778,127 | 83.80% | 16.20% | Net Buying | Net Selling |
APLS | APELLIS PHARMACEUTICALS INC | United States | $7.09B | 120,581,749 | 74.88% | 25.12% | Net Buying | Net Selling |
CVAC | CUREVAC NV | Germany | $678.37M | 223,883,084 | 9.84% | 0.00% |